FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1583812762> ?p ?o ?g. }

• W1583812762 endingPage "7485" @default.
• W1583812762 startingPage "7471" @default.
• W1583812762 abstract "// Peng Liu 1 , Zhipeng Wang 1 , Sarah Brown 1 , Vinodh Kannappan 1 , Patricia Erebi Tawari 1 , Wenguo Jiang 2 , Juan M. Irache 3 , James Z. Tang 1 , Stephen Britland 1 , Angel L. Armesilla 1 , John L. Darling 1 , Xing Tang 4 and Weiguang Wang 1 1 Research Institute in Healthcare Science, Faculty of Science & Engineering, University of Wolverhampton, Wolverhampton, UK 2 Cardiff University-Peking University Cancer Institute, Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, Cardiff, UK 3 School of Pharmacy, University of Navarra, Pamplona, Spain 4 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China Correspondence: Weiguang Wang, email: // Keywords : Breast cancer, cancer stem cells, Disulfiram, NFkappaB, chemoresistance Received : May 11, 2014 Accepted : July 3, 2014 Published : July 4, 2014 Abstract Breast cancer stem cells (BCSCs) are pan-resistant to different anticancer agents and responsible for cancer relapse. Disulfiram (DS), an antialcoholism drug, targets CSCs and reverses pan-chemoresistance. The anticancer application of DS is limited by its very short half-life in the bloodstream. This prompted us to develop a liposome-encapsulated DS (Lipo-DS) and examine its anticancer effect and mechanisms in vitro and in vivo . The relationship between hypoxia and CSCs was examined by in vitro comparison of BC cells cultured in spheroid and hypoxic conditions. To determine the importance of NFκB activation in bridging hypoxia and CSC-related pan-resistance, the CSC characters and drug sensitivity in BC cell lines were observed in NFκB p65 transfected cell lines. The effect of Lipo-DS on the NFκB pathway, CSCs and chemosensitivity was investigated in vitro and in vivo . The spheroid cultured BC cells manifested CSC characteristics and pan-resistance to anticancer drugs. This was related to the hypoxic condition in the spheres. Hypoxia induced activation of NFκB and chemoresistance. Transfection of BC cells with NFκB p65 also induced CSC characters and pan-resistance. Lipo-DS blocked NFκB activation and specifically targeted CSCs in vitro . Lipo-DS also targeted the CSC population in vivo and showed very strong anticancer efficacy. Mice tolerated the treatment very well and no significant in vivo nonspecific toxicity was observed. Hypoxia induced NFκB activation is responsible for stemness and chemoresistance in BCSCs. Lipo-DS targets NFκB pathway and CSCs. Further study may translate DS into cancer therapeutics." @default.
• W1583812762 created "2016-06-24" @default.
• W1583812762 creator A5016155416 @default.
• W1583812762 creator A5017993198 @default.
• W1583812762 creator A5018814025 @default.
• W1583812762 creator A5021525043 @default.
• W1583812762 creator A5025674242 @default.
• W1583812762 creator A5030100605 @default.
• W1583812762 creator A5034784139 @default.
• W1583812762 creator A5035783692 @default.
• W1583812762 creator A5037212165 @default.
• W1583812762 creator A5065935918 @default.
• W1583812762 creator A5085581800 @default.
• W1583812762 creator A5086543831 @default.
• W1583812762 creator A5089854622 @default.
• W1583812762 date "2014-07-04" @default.
• W1583812762 modified "2023-10-14" @default.
• W1583812762 title "Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells<i>in vitro</i>and<i>in vivo</i>" @default.
• W1583812762 cites W1911235202 @default.
• W1583812762 cites W1967291007 @default.
• W1583812762 cites W1974182237 @default.
• W1583812762 cites W1984172682 @default.
• W1583812762 cites W1987508250 @default.
• W1583812762 cites W1994707797 @default.
• W1583812762 cites W2000272522 @default.
• W1583812762 cites W2000932071 @default.
• W1583812762 cites W2002008095 @default.
• W1583812762 cites W2003060606 @default.
• W1583812762 cites W2004878973 @default.
• W1583812762 cites W2006414424 @default.
• W1583812762 cites W2007369931 @default.
• W1583812762 cites W2019784830 @default.
• W1583812762 cites W2020113271 @default.
• W1583812762 cites W2020131167 @default.
• W1583812762 cites W2023316892 @default.
• W1583812762 cites W2023427658 @default.
• W1583812762 cites W2023965930 @default.
• W1583812762 cites W2036180531 @default.
• W1583812762 cites W2041156138 @default.
• W1583812762 cites W2042176800 @default.
• W1583812762 cites W2043140203 @default.
• W1583812762 cites W2043271362 @default.
• W1583812762 cites W2043790885 @default.
• W1583812762 cites W2045208621 @default.
• W1583812762 cites W2055768563 @default.
• W1583812762 cites W2059167994 @default.
• W1583812762 cites W2061460308 @default.
• W1583812762 cites W2068981042 @default.
• W1583812762 cites W2070212400 @default.
• W1583812762 cites W2080510160 @default.
• W1583812762 cites W2084541153 @default.
• W1583812762 cites W2102212458 @default.
• W1583812762 cites W2103154710 @default.
• W1583812762 cites W2112740677 @default.
• W1583812762 cites W2115984906 @default.
• W1583812762 cites W2116715687 @default.
• W1583812762 cites W2134987819 @default.
• W1583812762 cites W2135943905 @default.
• W1583812762 cites W2140855200 @default.
• W1583812762 cites W2143372016 @default.
• W1583812762 cites W2159567970 @default.
• W1583812762 doi "https://doi.org/10.18632/oncotarget.2166" @default.
• W1583812762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4202137" @default.
• W1583812762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25277186" @default.
• W1583812762 hasPublicationYear "2014" @default.
• W1583812762 type Work @default.
• W1583812762 sameAs 1583812762 @default.
• W1583812762 citedByCount "96" @default.
• W1583812762 countsByYear W15838127622015 @default.
• W1583812762 countsByYear W15838127622016 @default.
• W1583812762 countsByYear W15838127622017 @default.
• W1583812762 countsByYear W15838127622018 @default.
• W1583812762 countsByYear W15838127622019 @default.
• W1583812762 countsByYear W15838127622020 @default.
• W1583812762 countsByYear W15838127622021 @default.
• W1583812762 countsByYear W15838127622022 @default.
• W1583812762 countsByYear W15838127622023 @default.
• W1583812762 crossrefType "journal-article" @default.
• W1583812762 hasAuthorship W1583812762A5016155416 @default.
• W1583812762 hasAuthorship W1583812762A5017993198 @default.
• W1583812762 hasAuthorship W1583812762A5018814025 @default.
• W1583812762 hasAuthorship W1583812762A5021525043 @default.
• W1583812762 hasAuthorship W1583812762A5025674242 @default.
• W1583812762 hasAuthorship W1583812762A5030100605 @default.
• W1583812762 hasAuthorship W1583812762A5034784139 @default.
• W1583812762 hasAuthorship W1583812762A5035783692 @default.
• W1583812762 hasAuthorship W1583812762A5037212165 @default.
• W1583812762 hasAuthorship W1583812762A5065935918 @default.
• W1583812762 hasAuthorship W1583812762A5085581800 @default.
• W1583812762 hasAuthorship W1583812762A5086543831 @default.
• W1583812762 hasAuthorship W1583812762A5089854622 @default.
• W1583812762 hasBestOaLocation W15838127621 @default.
• W1583812762 hasConcept C121608353 @default.
• W1583812762 hasConcept C126322002 @default.
• W1583812762 hasConcept C150903083 @default.
• W1583812762 hasConcept C185592680 @default.
• W1583812762 hasConcept C202751555 @default.
• W1583812762 hasConcept C207001950 @default.

• next